ENT Treatment Market
According to Intent Market Research, the ENT Treatment Market is expected to grow from USD 8.1 billion in 2023 at a CAGR of 6.4% to touch USD 12.6 billion by 2030. The ENT Treatment Market is dominated by key players such as, Abbott Laboratories, Johnson & Johnson, Merck & Co., Inc., Bayer AG, and Pfizer Inc